Microarray Analysis of Long Non-Coding RNAs and Messenger RNAs in a Mouse Model of Oxygen-Induced Retinopathy

Lusi Zhang1,2, Xiaolin Fu1,2,3, Huilan Zeng1,2

  • 1Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.

Insights

This study profiles long non-coding RNAs (lncRNAs) and messenger RNAs (mRNAs) in oxygen-induced retinopathy (OIR) mice. Altered lncRNA and mRNA expression reveals potential therapeutic targets for retinal neovascularization.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Genetics

Background:

  • Retinal neovascularization is a severe complication in ocular diseases.
  • Long non-coding RNAs (lncRNAs) and messenger RNAs (mRNAs) may play roles in this process.

Purpose of the Study:

  • To investigate the expression profiles of lncRNAs and mRNAs in a mouse model of oxygen-induced retinopathy (OIR).
  • To identify potential therapeutic targets for retinal neovascularization.

Main Methods:

  • Microarray analysis to identify differentially expressed lncRNAs and mRNAs in OIR mice.
  • Quantitative real-time PCR (qRT-PCR) for validation.
  • Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses.
  • Construction of a coding-non-coding gene co-expression (CNC) network.

Main Results:

  • 198 lncRNAs and 412 mRNAs were up-regulated; 175 lncRNAs and 127 mRNAs were down-regulated in OIR mice.
  • Altered mRNAs were enriched in immune processes and ECM-receptor interactions.
  • CNC network analysis revealed interactions between lncRNAs and mRNAs involved in angiogenesis and leukocyte migration.

Conclusions:

  • Altered lncRNA and mRNA profiles are crucial for understanding the pathogenesis of ischemia-induced retinal neovascularization.
  • lncRNAs represent potential therapeutic targets for treating retinal neovascularization.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.6K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.5K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.6K
Small interfering RNAs (siRNA)02:30

Small interfering RNAs (siRNA)

4.3K
What are Second Messengers?01:12

What are Second Messengers?

Because many receptor binding ligands are hydrophilic, they do not cross the cell membrane and thus their message must be relayed to a second messenger on the inside. There are several second messenger pathways, each with their own way of relaying information. G-protein coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol path is active when the receptor induces phospholipase C to hydrolyze the phospholipid,...
90.4K